Personalised Modeling and Simulations for the Differential Diagnosis of Dynapenia: Study on Patients With Osteoarthritis
NCT05795348 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-05-29
Summary
The ForceLoss study aims to develop personalised modeling and simulation procedures to enable the differential diagnosis for the loss of muscle force, namely dynapenia. The primary causes of dynapenia can be identified in a diffuse or selective sarcopenia, a lack of activation (inhibition), or suboptimal motor control. Each of these causes requires different interventions, but a reliable differential diagnosis is currently impossible. While biomedical instruments and tools can provide valuable information, it is often left to the experience of the single clinican to integrate such information into a complete diagnostic picture. An accurate diagnosis for dynapenia is important for a number of pathologies, including neurological diseases, age-related frailty, diabetes, and orthopaedic conditions.
The hypothesis is that the use of mechanistic, subject-specific models (digital twins) to simulate a maximal isometric knee extension task, informed by experimental measures may be employed to conduct a robust differential diagnosis for dynapenia.
In this study, on patients candidate for knee arthroplasty, the investigators will expand (i) the experimental protocol previously developed and tested on healthy volunteers with a measure of involuntary muscle contraction (superimposed neuromuscular electrical stimulation, SNMES), a hand-grip test, measures of bio-impedance and clinical questionnaires, and (ii) the modeling and simulation framework to include one additional step (to check for muscle inhibition).
Medical imaging, electromyography (EMG) and dynamometry data will be collected and combined to inform a digital twin of each participant. Biomechanical computer simulations of a Maximal Voluntary Isometric Contraction (MVIC) task will then be performed. Comparing the models' estimates to in vivo dynamometry measurements and EMG data, the investigators will test one by one the three possible causes of dynapenia, and, through a process of hypothesis falsification will exclude those that do not explain the observed loss of muscle force.
Conditions
- Osteoarthritis, Knee
Interventions
- DIAGNOSTIC_TEST
-
Personalised Musculoskeletal Modeling
Magnetic resonance images, electromyography and dynamometry data will be used to develop and inform personalised musculoskeletal models
Sponsors & Collaborators
-
Istituto Ortopedico Rizzoli
lead OTHER
Principal Investigators
-
Marco Viceconti, Professor · IRCCS Istituto Ortopedico Rizzoli
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 65 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-28
- Primary Completion
- 2024-05-27
- Completion
- 2024-05-27
Countries
- Italy
Study Locations
More Related Trials
-
Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
NCT03409120 ·Status: COMPLETED ·Phase: NA
-
Dystonia Image-based Programming of Stimulation: A Prospective, Randomized, Double-blind Crossover Trial
NCT05097001 ·Status: RECRUITING ·Phase: NA
-
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
NCT02125825 ·Status: COMPLETED
-
Action Observation Treatment in Parkinson's Patients
NCT04181918 ·Status: UNKNOWN ·Phase: NA
-
Evolution of Hypodopaminergic Syndrome in Early Parkinson's Disease
NCT03141944 ·Status: COMPLETED
-
[18F]F-DOPA Imaging in Patients With Autonomic Failure
NCT04246437 ·Status: RECRUITING ·Phase: PHASE1
-
Loss of Depotentiation in Focal Dystonia
NCT03206112 ·Status: TERMINATED
-
eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.
NCT04990284 ·Status: COMPLETED ·Phase: PHASE4
-
High Intensity Focused Ultrasound for X-linked Dystonia-parkinsonism
NCT05592028 ·Status: AVAILABLE
-
Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia
NCT00169403 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens
NCT01296464 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
NCT05557864 ·Status: RECRUITING ·Phase: NA
-
Transdermal Rotigotine User Surveillance Study
NCT00599339 ·Status: COMPLETED
-
Characterization of Dynamic Stability in Normal Pressure Hydrocephalus and Parkinson's Disease
NCT05998473 ·Status: UNKNOWN
-
Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
NCT01014858 ·Status: TERMINATED ·Phase: PHASE3
-
Crossover Versus Stabilometric Platform in Parkinson's Disease
NCT02098577 ·Status: COMPLETED
-
Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological Study
NCT01020682 ·Status: UNKNOWN
-
Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease
NCT03517059 ·Status: COMPLETED
-
Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases
NCT06318585 ·Status: RECRUITING
-
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
NCT06115538 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Multicenter Study of Blood Biomarkers of Mitochondrial and Peroxisomal Metabolism to Differentiate Idiopathic Parkinson's Disease From Related Conditions
NCT05110547 ·Status: UNKNOWN
-
Superior Cervical Ganglion in Parkinson's Disease
NCT05741151 ·Status: RECRUITING ·Phase: NA
-
Asymmetric Targeted DBS for PD With PIGD
NCT05397340 ·Status: UNKNOWN ·Phase: NA
-
Progression of Striatal and Extrastriatal Degeneration in PD and PSP Patients
NCT03840252 ·Status: COMPLETED ·Phase: NA